MedPath

Pelvic Microbiomes of Benign and Malignant Ovarian Diseases

Conditions
Ovarian Neoplasms
Ribosome Alteration
Microbiota
Interventions
Diagnostic Test: microbiomes
Registration Number
NCT03388996
Lead Sponsor
Lei Li
Brief Summary

This case-control study aims to compare the pelvic microbiomes of benign ovarian diseases and ovarian malignancies by 16s RNA techniques and culture. Discharges/flushing fluid from vagina, faces and fimbria end of fallopian tube are collected from age and menopausal status matched patient before and during procedures of laparoscopies. The discharges/flushing fluid would be sent for 16s RNA analysis and microculture respectively, and the results would get self-contrasted comparison and case-control comparison.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Laparoscopy procedures
  • Specific pathological diagnosis
Exclusion Criteria
  • Previous history of pelvic surgeries
  • Evidences of pelvic inflammation diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Benign ovarian diseasemicrobiomesThe group consists of patients of benign ovarian diseases and health conditions (eg infertility), who would accept the tests of pelvic microbiomes.
Malignant ovarian diseasemicrobiomesThe group consists of patients of high grade serous carcinoma, who would accept the tests of pelvic microbiomes.
Primary Outcome Measures
NameTimeMethod
Difference of species distribution of microorganism according to 16s RNA analysis2 years

The difference of species of microorganism distribution according to 16s RNA sequencing analysis between control group and study group, and between different sampling sites in each arm

Difference of species distribution of microorganism according to microculture outcomes2 years

Difference of species distribution of microorganism according to microculture outcomes between control group and study group, and between different sampling sites in each arm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath